Levocabastina [Spanish] en es it fr

Levocabastina [Spanish] Brand names, Levocabastina [Spanish] Analogs

Levocabastina [Spanish] Brand Names Mixture

  • No information avaliable

Levocabastina [Spanish] Chemical_Formula


Levocabastina [Spanish] RX_link


Levocabastina [Spanish] fda sheet

Levocabastina_[Spanish] FDA

Levocabastina [Spanish] msds (material safety sheet)

Levocabastina [Spanish] Synthesis Reference

No information avaliable

Levocabastina [Spanish] Molecular Weight

351.348 g/mol

Levocabastina [Spanish] Melting Point

239-240.5 oC

Levocabastina [Spanish] H2O Solubility

27.2 mg/mL

Levocabastina [Spanish] State


Levocabastina [Spanish] LogP


Levocabastina [Spanish] Dosage Forms


Levocabastina [Spanish] Indication

For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: S.pneumoniae, H.influenzae, S.aureus, P.aeruginosa, E. cloacae, P. mirabilis, C. civersus, S. asprphyticus, E.coli, and K.pneumoniae.

Levocabastina [Spanish] Pharmacology

Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as E.coli and Neisseria gonorrhoea as well as gram-positive bacteria including S. pneumoniae and Staphylococcus aureus. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.

Levocabastina [Spanish] Absorption

Rapid and nearly complete with approximately 95% to 98% of a single oral dose being absorbed.

Levocabastina [Spanish] side effects and Toxicity

Adverse reactions include peripheral neuropathy, nervousness, agitation, anxiety, and phototoxic events (rash, itching, burning) due to sunlight exposure.

Levocabastina [Spanish] Patient Information

Levocabastina [Spanish] Organisms Affected

Enteric bacteria and other eubacteria